Front. Pharmacol.Frontiers in PharmacologyFront. Pharmacol.1663-9812Frontiers Media S.A.146861210.3389/fphar.2024.1468612PharmacologyCorrectionCorrigendum: Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injuryLuo et al.10.3389/fphar.2024.1468612LuoXinyao1†ZhouWeijian1†WanDingyuan2PengJing1LiaoRuoxi1*SuBaihai1*1Department of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, China2Department of Intensive Care Medicine, West China Hospital, Sichuan University, Chengdu, China
Edited and reviewed by:Giuseppe Remuzzi, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy
*Correspondence: Baihai Su, subaihai@scu.edu.cn; Ruoxi Liao, lrx-wch@foxmail.com
These authors have contributed equally to this work and share first authorship
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury by Luo X, Zhou W, Wan D, Peng J, Liao R and Su B (2024). Front. Pharmacol. 15:1409654. doi: 10.3389/fphar.2024.1409654acute kidney injuryamoxicillinintensive care unitmortalityacute kidney diseasesection-at-acceptanceRenal Pharmacology
In the published article, there was an error in Figure 2 as published. Figure 2 contains superfluous elements. The corrected Figure 2 and its caption appear below.
The association between amoxicillin administration and clinical outcomes in patients with AKI. (A) Association between amoxicillin administration and clinical outcomes. Four different methods were used to address the associations: 1) univariable Cox regression, 2) multivariable Cox regression, 3) propensity score matching, and 4) inverse propensity weighted modeling. (B) Kaplan‒Meier survival curves of the amoxicillin group and non-amoxicillin group after PSM for 30-day mortality. (C) Kaplan‒Meier survival curves of the amoxicillin group and non-amoxicillin group after PSM for 30-day mortality. Notes: HRs (95% CIs) were derived from Cox proportional hazards regression models. Covariates were adjusted as in the model II. The MDs (95% CIs) were derived from linear regression models. Covariates were adjusted as in the model II. Abbreviations: HR, hazard ratio; MD mean difference; PSM, propensity score matching; IPTW, inverse probability of treatment weighting; ICU, intensive care unit.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.